ceric oxide has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharadwaj, S; Kaushik, AC; Kumar, S; Wei, DQ | 1 |
| Alasady, AA; Aziz, FM; Falahati, M; Hasan, A; Khaki, PA; Qadir Nanakali, NM; Salihi, A; Shahpasand, K; Sharifi, M; Zand, Z | 1 |
2 other study(ies) available for ceric oxide and alpha-synuclein
| Article | Year |
|---|---|
Nano-particle mediated inhibition of Parkinson's disease using computational biology approach.
Topics: alpha-Synuclein; Blood-Brain Barrier; Cerium; Humans; Molecular Dynamics Simulation; Nanoparticles; Parkinson Disease | 2018 |
Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity.
Topics: alpha-Synuclein; Amyloid; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Cell Line, Tumor; Cerium; Congo Red; Humans; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Nanoparticles; Necrosis; RNA, Messenger; Spectrometry, Fluorescence | 2019 |